HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in HTG Molecular Diagnostics, Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −8 vs. Q3 2022
- Shares held
- 16.5K
- −22.1K (−57.3%) vs. Q3 2022Converted for a 1-for-12 split
- Total value
- $66.2K
- −$216.8K (−76.6%) vs. Q3 2022
- New holders
- 0
- 3 more added
- Sold out
- 8
- 4 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 12 | $67.3K |
| Q4 2022 | 10 | $66.2K |
| Q3 2022 | 19 | $283.0K |
| Q2 2022 | 22 | $622.0K |
| Q1 2022 | 22 | $3.19M |
| Q4 2021 | 23 | $14.5M |
| Q3 2021 | 23 | $16.4M |
| Q2 2021 | 25 | $19.7M |
| Q1 2021 | 23 | $11.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1 | $0 | 0.00% | −1−53.8% | ReducedConverted for a 1-for-12 split |
| Royal Bank of Canada | 4 | $0 | 0.00% | −4−49.5% | ReducedConverted for a 1-for-12 split |
| TCI Wealth Advisors, Inc. | 2 | $8 | 0.00% | −0−7.7% | ReducedConverted for a 1-for-12 split |
| Wells Fargo & Company | 4 | $16 | 0.00% | +0+4.3% | AddedConverted for a 1-for-12 split |
| Allworth Financial LP | 277 | $1.10K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| HighMark Wealth Management LLC | 580 | $2.31K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Morgan Stanley | 884 | $3.53K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| UBS Group AG | 1,975 | $7.88K | 0.00% | +1,973+91,053.8% | AddedConverted for a 1-for-12 split |
| BlackRock Inc. | 6,104 | $24.4K | 0.00% | −79−1.3% | ReducedConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 6,689 | $27.0K | 0.00% | +6,313+1,680.6% | AddedConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −7,200−100.0% | Sold outConverted for a 1-for-12 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,038−100.0% | Sold outConverted for a 1-for-12 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −5,910−100.0% | Sold outConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −3,931−100.0% | Sold outConverted for a 1-for-12 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,288−100.0% | Sold outConverted for a 1-for-12 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,974−100.0% | Sold outConverted for a 1-for-12 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,805−100.0% | Sold outConverted for a 1-for-12 split |
| State Street Corp | 0 | $0 | 0.00% | −1,205−100.0% | Sold outConverted for a 1-for-12 split |
| Surevest, LLC | – | – | – | – | Not filed |